SCHEMBL17099458

SCHEMBL17099458

CC(CN1c2cc(Br)ccc2CC1(C)C)C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.43
HTR2C P28335 3/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
NFKB1 P19838 1/20 0.43
HTR2B P41595 1/20 0.43
HIF1A Q16665 1/20 0.43
LMNA P02545 1/20 0.42
PMP22 Q01453 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
GFER P55789 1/20 0.42
DPP8 Q6V1X1 1/20 0.37
DPP9 Q86TI2 1/20 0.37
DPP7 Q9UHL4 1/20 0.37
XIAP P98170 2/20 0.34
BIRC2 Q13490 2/20 0.34
HSD17B3 P37058 3/20 0.33
EPHX1 P07099 2/20 0.33
HDAC1 Q13547 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29209110 0.67 OPRM1 (0.39) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL17099543 0.67 NPC1 (0.36) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
Isobutyramide SCHEMBL17099457 0.63 HPGD (0.39) GFERDPP8DPP9DPP7
SCHEMBL9082861 0.61 SLC22A12 (0.41) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL7674586 0.61 HTR2A (1.00) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL28838934 0.61 HSD17B3 (0.42) DPP8DPP9DPP7HSD17B3CARM1
SCHEMBL29462310 0.61 HTR2A (1.00) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL905755 0.61 HTR2A (1.00) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL19016045 0.60 BRD4 (0.35) HTR2AHTR2CCYP1A2CYP3A4CYP2D6
SCHEMBL22447473 0.59 MCL1 (0.63) LMNAHDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015143376-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS NIVALIS THERAPEUTICS, INC. (US) 2015-09-24 WO disclosed